Form 8-K - Current report:
SEC Accession No. 0001493152-24-041362
Filing Date
2024-10-17
Accepted
2024-10-17 07:00:25
Documents
35
Period of Report
2024-10-17
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42264
2 ex99-1.htm EX-99.1 16403
3 ex99-1_001.jpg GRAPHIC 414086
4 ex99-1_002.jpg GRAPHIC 1611372
5 ex99-1_003.jpg GRAPHIC 744353
6 ex99-1_004.jpg GRAPHIC 1063128
7 ex99-1_005.jpg GRAPHIC 1682246
8 ex99-1_006.jpg GRAPHIC 890019
9 ex99-1_007.jpg GRAPHIC 883426
10 ex99-1_008.jpg GRAPHIC 1216277
11 ex99-1_009.jpg GRAPHIC 680080
12 ex99-1_010.jpg GRAPHIC 1039726
13 ex99-1_011.jpg GRAPHIC 1129515
14 ex99-1_012.jpg GRAPHIC 1229165
15 ex99-1_013.jpg GRAPHIC 843769
16 ex99-1_014.jpg GRAPHIC 1029411
17 ex99-1_015.jpg GRAPHIC 836976
18 ex99-1_016.jpg GRAPHIC 1071201
19 ex99-1_017.jpg GRAPHIC 1045491
20 ex99-1_018.jpg GRAPHIC 989267
21 ex99-1_019.jpg GRAPHIC 1184879
22 ex99-1_020.jpg GRAPHIC 610143
23 ex99-1_021.jpg GRAPHIC 1196311
  Complete submission text file 0001493152-24-041362.txt   29656400

Data Files

Seq Description Document Type Size
24 XBRL SCHEMA FILE aneb-20241017.xsd EX-101.SCH 3012
25 XBRL LABEL FILE aneb-20241017_lab.xml EX-101.LAB 34240
26 XBRL PRESENTATION FILE aneb-20241017_pre.xml EX-101.PRE 24163
37 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3963
Mailing Address JFL CAPITAL MANAGEMENT 1017 RR 620 S, SUITE 107 LAKEWAY TX 78734
Business Address JFL CAPITAL MANAGEMENT 1017 RR 620 S, SUITE 107 LAKEWAY TX 78734 737 203 5270
Anebulo Pharmaceuticals, Inc. (Filer) CIK: 0001815974 (see all company filings)

EIN.: 851170950 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-40388 | Film No.: 241375910
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)